MARY ELLEN ESTES: Open Payments
NPI 1447427000 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 18 payments from 10 companies in 2025. Trend: 2023 $1,022 · 2024 $483 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $111 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Amgen Inc. | 5 | $103 |
| Novo Nordisk Inc | 4 | $76 |
| Lilly USA, LLC | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Bausch Health US, LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: DUPIXENT, ZENPEP, Auvelity, OTEZLA, EVENITY, MOUNJARO, Rybelsus, INSPIRE.
Industry payments across VA — which companies pay providers there.
